Rosenblum Silverman Sutton’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$412K Sell
3,486
-6,348
-65% -$785K 0.11% 66
2025
Q4
$1.24M Sell
9,834
-24,620
-71% -$3.21M 0.29% 47
2025
Q3
$5.04M Sell
34,454
-3,860
-10% -$583K 1.15% 28
2025
Q2
$5.98M Sell
38,314
-360
-0.9% -$57.1K 1.45% 23
2025
Q1
$6.37M Sell
38,674
-1,561
-4% -$260K 1.75% 20
2024
Q4
$6.56M Sell
40,235
-290
-0.7% -$51.9K 1.65% 20
2024
Q3
$7.92M Sell
40,525
-20
-0% -$3.69K 2.03% 17
2024
Q2
$7.03M Buy
40,545
+915
+2% +$152K 1.88% 20
2024
Q1
$6.71M Buy
+39,630
New +$7.42M 1.9% 19

Other funds holding ZTS

Rosenblum Silverman Sutton's ZTS Position: Q1 2026 in Review

Rosenblum Silverman Sutton reduced its Zoetis (ZTS) stake by 65% in Q1 2026, selling an estimated $785K and leaving 3,486 shares worth $412K. The position accounts for 0.11% of the portfolio, ranked #66.

Rosenblum Silverman Sutton first reported a position in ZTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.92M in Q3 2024. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Rosenblum Silverman Sutton held 3,486 shares of Zoetis worth $412K as of Q1 2026.
  • Rosenblum Silverman Sutton sold 6,348 Zoetis shares in Q1 2026, an estimated $785K.
  • Zoetis made up 0.11% of Rosenblum Silverman Sutton's portfolio in Q1 2026, its #66 holding.
  • Rosenblum Silverman Sutton first reported a position in Zoetis in Q1 2024 and has held it in 9 quarters since.
  • Rosenblum Silverman Sutton's Zoetis position peaked at $7.92M in Q3 2024.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Rosenblum Silverman Sutton's 13F filing for Q1 2026, filed 13 May 2026.